Alerts will be sent to your verified email
Verify EmailMEDICAMEQ
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Medicamen Biotech Limited is a pharmaceutical company that manufactures and markets a variety of pharmaceutical formulations globally. Its product range includes tablets, capsules, liquid syrups, and dry syrups.
Medicamen Biotech major competitors are Shivalik Rasayan, Medico Remedies, Albert David, Trident Lifeline, Prevest Denpro, Jenburkt Pharma, Vaidya Sane Ayur Lab.
Market Cap of Medicamen Biotech is ₹373 Crs.
While the median market cap of its peers are ₹411 Crs.
Medicamen Biotech seems to be less financially stable compared to its competitors.
Altman Z score of Medicamen Biotech is 4.62 and is ranked 5 out of its 8 competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | |||||||||||||||||||
| Investor Presentation | Sep | Mar Sep Dec | Sep | Mar Jun Sep | Jun | Jun Sep | |||||||||||||
| Conference Call | |||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
